Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.
about
Neuroendocrine differentiation in prostate cancerDrug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An OverviewMolecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancerOriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agentsF-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferationFBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrestF-box protein FBXL2 exerts human lung tumor suppressor-like activity by ubiquitin-mediated degradation of cyclin D3 resulting in cell cycle arrestEngineered silybin nanoparticles educe efficient control in experimental diabetesAltered prostatic epithelial proliferation and apoptosis, prostatic development, and serum testosterone in mice lacking cyclin-dependent kinase inhibitorsHigh-affinity binding of silybin derivatives to the nucleotide-binding domain of a Leishmania tropica P-glycoprotein-like transporter and chemosensitization of a multidrug-resistant parasite to daunomycin.Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells.Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceSilibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulatorsSilibinin suppresses CD44 expression in prostate cancer cellsThe flavonoid apigenin downregulates CDK1 by directly targeting ribosomal protein S9.Flavonoids: A versatile source of anticancer drugs.From chemoprevention to chemotherapy: common targets and common goals.Silibinin Inhibits Platelet-Derived Growth Factor-Driven Cell Proliferation via Downregulation of N-Glycosylation in Human Tenon's Fibroblasts in a Proteasome-Dependent MannerMultifocal angiostatic therapy: an update.Silymarin and epithelial cancer chemoprevention: how close we are to bedside?Silibinin inhibits VEGF secretion and age-related macular degeneration in a hypoxia-dependent manner through the PI-3 kinase/Akt/mTOR pathway.Advances in the use of milk thistle (Silybum marianum).Chemopreventive efficacy of silymarin in skin and prostate cancer.Combinatorial strategies for cancer eradication by silibinin and cytotoxic agents: efficacy and mechanisms.Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats.Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.Targeting silibinin in the antiproliferative pathway.Combinatorial strategies employing nutraceuticals for cancer development.Advances in prostate cancer chemoprevention: a translational perspective.The strategies to control prostate cancer by chemoprevention approaches.5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.Schlafen 12 expression modulates prostate cancer cell differentiation.Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signalingCell growth inhibition and down-regulation of survivin by silibinin in a laryngeal squamous cell carcinoma cell line.Pressurized water versus ethanol as a Silybum marianum extraction solvent for inhibition of low-density lipoprotein oxidation mediated by copper and J774 macrophage cells.
P2860
Q24657547-A853E70C-A7CF-470C-AF20-6795065678FFQ26767516-A1946CA9-F937-4CA9-A958-2210767D296EQ26995304-DE6B4C4C-D5FC-48CD-8833-77973BC1DFB4Q28242416-6B47A449-ED5E-4BE3-B08C-183AB42CD30AQ28383185-14D637A6-359D-4D19-B12F-C571BA213B0BQ28396015-21679DAF-B62C-408C-A9A9-2158B7A25A8AQ28396057-1B06D46E-6B19-44B7-B920-E125B8D383AEQ28540351-65A5E1E5-7ECB-48C4-BFC6-1772E12E78B9Q28591408-5BA58273-B19B-41BC-AFC5-837DAAC79BCEQ33981351-2C5E093E-4862-4CC6-A070-5729229D013BQ34027884-4EFC1BC8-177C-441D-AC91-67CA3DE12631Q34110103-70E3CB2F-D7E8-4B1B-9A07-416F22CF9864Q34505037-CBEDE90D-55CA-4712-9558-2373A83A8B9FQ34627739-979BA729-4287-43D6-9AEB-952F0727686FQ34659546-8556FBC1-1862-46DC-8354-E2F1D2D49169Q34979753-ABCCB94E-3F0B-452D-8A56-2769A4832749Q35533265-C495CD09-AD28-4AB5-BF31-EB5E6A4A32E0Q35906984-2D254BA5-266A-4033-8F81-A7324799EC97Q36234820-4CF52B36-C68A-4C08-AB12-2D9418E12519Q36311166-7B4BD968-BE5D-4CC4-86FC-999B3FEFD95DQ36690472-6B376EAB-ED19-4B53-A1F1-FBD26B95A394Q36781055-2D2E2A44-167C-4FCC-98A6-505089932FCDQ36840433-D0C77AAB-4109-48E9-9DF5-1E4C569D961BQ36840442-D1C7697F-B7CD-4108-AA23-E7C156651062Q36920794-E3D939ED-D91F-41F5-A033-2FEB428DA3CDQ37033850-73303503-040D-4D09-9961-0C8A27BA873FQ37591742-33E31DF1-45E0-472A-88F1-BF92A975E647Q37667106-37DCB822-F557-4945-A673-977A909B8A26Q37906730-DC69705B-F72B-40A0-BC4A-4AEBD7CF7EEEQ38107513-0CBEEDA4-52FD-456E-9E91-DD6578FD4F52Q38175776-67CF436E-C343-489C-9977-370F1BD41111Q38653651-7B99D17A-BB89-4155-B4CF-5ECC08A8DF4EQ38766644-62AFCF64-8C6F-4D52-99C8-FD8BE09EE5EFQ38805238-BF2EE4E2-9922-4F5D-BE55-FCE463171045Q38949811-68EB9FAD-9D44-446E-96EB-55BE1A66FAA3Q39001150-DBCA1404-DE17-4491-AD25-641EFC4ADA77Q39002801-6EE215A2-A80A-4773-8E11-7263370DC01FQ39894607-8E7F573A-54E0-4F0B-B210-654EF928F2A1Q39919197-96180044-6461-41AE-9DF7-262BE13E975DQ40038072-C693BE7C-29DA-4391-913E-FF614C13116C
P2860
Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Silibinin decreases prostate-s ...... prostate cancer intervention.
@ast
Silibinin decreases prostate-s ...... prostate cancer intervention.
@en
type
label
Silibinin decreases prostate-s ...... prostate cancer intervention.
@ast
Silibinin decreases prostate-s ...... prostate cancer intervention.
@en
prefLabel
Silibinin decreases prostate-s ...... prostate cancer intervention.
@ast
Silibinin decreases prostate-s ...... prostate cancer intervention.
@en
P2860
P356
P1476
Silibinin decreases prostate-s ...... prostate cancer intervention.
@en
P2860
P304
P356
10.1073/PNAS.96.13.7490
P407
P577
1999-06-01T00:00:00Z